Does DASATINIB Cause Myelosuppression? 48 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Myelosuppression have been filed in association with DASATINIB (dasatinib). This represents 0.2% of all adverse event reports for DASATINIB.
48
Reports of Myelosuppression with DASATINIB
0.2%
of all DASATINIB reports
3
Deaths
13
Hospitalizations
How Dangerous Is Myelosuppression From DASATINIB?
Of the 48 reports, 3 (6.3%) resulted in death, 13 (27.1%) required hospitalization, and 3 (6.3%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
Yes, Myelosuppression is listed as a known adverse reaction in the official FDA drug label for DASATINIB.
What Other Side Effects Does DASATINIB Cause?
Pleural effusion (2,424)
Fatigue (2,173)
Death (1,741)
Nausea (1,740)
Diarrhoea (1,728)
Headache (1,625)
Adverse event (1,382)
Rash (1,300)
Drug ineffective (1,271)
Hospitalisation (1,181)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which DASATINIB Alternatives Have Lower Myelosuppression Risk?
DASATINIB vs DATOPOTAMAB DERUXTECAN-DLNK
DASATINIB vs DAUNORUBICIN
DASATINIB vs DAXIBOTULINUMTOXIN A-LANM
DASATINIB vs DAYTRANA
DASATINIB vs DECITABINE